Back to search
Collagenous Colitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Collagenous Colitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Collagenous Colitis trials you may qualify forThe hypothesis of this study is that an altered gut microbiota is a contributory factor in initiating an inflammatory process in the colonic mucosa leading to c…
The purpose of the study is to assess among others environmental and hygiene-related risk factors for microscopic colitis (MC), a common diarrheal disease.
This study aims to demonstrate the superiority of budesonide compared to placebo as maintenance therapy in keeping patients in remission over a one-year period
The purpose of this study is to determine whether chromoendoscopy using Indigo-Carmine dye spray is useful in diagnosing microscopic colitis among patients unde…
The study compares the effect of Budesonide, Bismuth and fiber in patients with microscopic colitis
The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of collagenous colitis.
The purpose of this study is to determine whether orale budesonide is effective in maintaining clinical remission in patients with collagenous colitis.
The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter…